We are excited to announce that GuRu Wireless (fka Auspion), will be unveiling 3 prototypes at the Consumer Electronics...
Read more
3D Bio announced that the FDA has granted Rare Pediatric Disease designation for AuriNovo™, an investigational combination product for...
Read more
Congratulations to the leadership team at MixComm, Inc. for recruiting Aristotele Hadjichristos as Vice President of Product Development.
Read more
3D Bio has received Orphan Drug Designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear...
Read more
Congratulations to our portfolio company Tanvas on being named a Cool Vendor in Gartner, Inc.'s report Cool Vendors...
Read more
Actuate Therapeutics, Inc. has raised an additional $6.5M in a Series B-3 financing round led by Bios Partners with...
Read more
GuRu, a millimeter-wave (mmWave) technology company, has raised $15 million in Series A funding backed by Kairos Ventures and...
Read more
Congratulations to MixComm for securing $8.6M in Series B funding. Led by Kairos Ventures, these funds will be used...
Read more
Congratulations to Provivi for completing an $85 million Series C financing! Proceeds from the Series C financing will support...
Read more
The National Institutes of Health (NIH) has awarded Delpor, Inc. a grant for the development of a Once-Yearly Naltrexone...
Read more